【NMPA】7 New Registration Technical Review Guidelines

Mar 10, 2020 from CIRS by Yolanda

On March 5, 2020, the NMPA issued

- Guidelines for the Technical Review of Registration of Colloidal Gold Immunochromatographic Analyzers

- Guidelines for the Technical Review of Registration of Follicle-stimulating Hormone Detection Reagents

- Guidelines for the Technical Review of Registration of Creatinine Detection Reagents

- Guidelines for the Technical Review of Registration of Antinuclear Antibody Detection Reagents

- Guidelines for the Technical Review of Registration of Antithyroid Peroxidase Antibody Testing Reagents

- Guidelines for the Technical Review of Registration of Glycated Albumin Assay Reagents and

- Guidelines for the Technical Review of the Registration of Total Bile Acid Determination Reagents

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Previous: Summary of the 2019 Medical Device Registration Report

Next: [Analysis][NMPA] The transfer of the production of imported medical devices to Chinese enterprises

+86 571 8720 6559 （GMT+8 8:30~17:00）

md@cirs-group.com

+86 571 8720 6559 （GMT+8 8:30~17:00）

md@cirs-group.com